Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms
2020/02/14 by Lisa A. Lewis, Sanjay Ram · 27 citations
Immunology and Microbiology · Medicine · #Bacterial Infections and Vaccines #Complement system in diseases #Blood groups and transfusion
paper · doi:10.1002/1873-3468.13760
Abstract
Neisseria gonorrhoeae causes the sexually transmitted infection gonorrhea, while Neisseria meningitidis is an important cause of bacterial meningitis and sepsis. Complement is a central arm of innate immune defenses and plays an important role in combating Neisserial infections. Persons with congenital and acquired defects in complement are at a significantly higher risk for invasive Neisserial infections such as invasive meningococcal disease and disseminated gonococcal infection compared to the general population. Of note, Neisseria gonorrhoeae and Neisseria meningitidis can only infect humans, which in part may be related to their ability to evade only human complement. This review summarizes the epidemiologic and clinical aspects of Neisserial infections in persons with defects in the complement system. Mechanisms used by these pathogens to subvert killing by complement and preclinical studies showing how these complement evasion strategies may be used to counteract the global threat of meningococcal and gonococcal infections are discussed.
Cited by
- Sweet turning bitter: Carbohydrate sensing of complement in host defence and disease
- Neisseria gonorrhoeae: mechanisms of immune evasion, antimicrobial resistance, and vaccine development challenges
- Drug Targeting a Gonococcal Virulence Factor Exploits Host Antimicrobial Peptides in Clearance of Infection. [europepmc]
- Infections in the Era of Targeted Therapies: Mapping the Road Ahead. [europepmc]
- Hijacking Factor H for Complement Immune Evasion. [europepmc]
- Emerging roles of the complement system in host-pathogen interactions. [europepmc]
- Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals. [europepmc]
- Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018. [europepmc]
- The Host-Pathogen Interactions and Epicellular Lifestyle of Neisseria meningitidis . [europepmc]
- Meningococcal virulence in zebrafish embryos depends on capsule polysaccharide structure. [europepmc]
- CanB is a metabolic mediator of antibiotic resistance in Neisseria gonorrhoeae. [europepmc]
- OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans. [europepmc]
- In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway. [europepmc]
- Immune responses to Neisseria gonorrhoeae and implications for vaccine development. [europepmc]
- The first case report of complement component 7 deficiency in Qatar and a 10-year follow-up. [europepmc]
- Evaluating vaccine-elicited antibody activities against Neisseria gonorrhoeae : cross-protective responses elicited by the 4CMenB meningococcal vaccine. [europepmc]
- Microevolution and Its Impact on Hypervirulence, Antimicrobial Resistance, and Vaccine Escape in Neisseria meningitidis . [europepmc]
- A National Advisory Committee on Immunization (NACI) update on invasive meningococcal disease (IMD) epidemiology and program-relevant considerations for preventing IMD in individuals at high risk of exposure. [europepmc]
- Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance. [europepmc]
- Rational selection of TbpB variants yields a bivalent vaccine with broad coverage against Neisseria gonorrhoeae. [europepmc]
- Genetic variability in Neisseria meningitidis strains isolated in a Japanese hospital. [europepmc]
- Terminal complement complexes with or without C9 potentiate antimicrobial activity against Neisseria gonorrhoeae . [europepmc]
- Isolation of human monoclonal antibodies from 4CMenB vaccinees reveals PorB and LOS as the main OMV components inducing cross-strain protection. [europepmc]
- The life-and-death struggle between the complement system and pathogens: Mechanisms of elimination, evasion tactics, and translational potential. [europepmc]
- Gonococcal outer membrane vesicle vaccines: bacterial population biology, clinical trials, immune profiling, and vaccine design. [europepmc]
- A microphysiologic human cervical model recapitulates microbial, immune, and pathogenic properties of sexually transmitted infections. [europepmc]
- Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland. [europepmc]
Related